US14280C1053
US14280C1053
Carlsmed, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 393.71M EUR | 283.04M EUR | 246.45M EUR | 329.3M EUR |
Enterprise Value | 316.3M EUR | 258.71M EUR | 190.69M EUR | 260.92M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -10.45x | -- | -- | -- |
Price to Sales | 6.22x | 4.47x | 4.37x | 8.17x |
Price to Book | 4.66x | 3.36x | 2.67x | 3.33x |
EV/Revenue | 5x | 4.09x | 3.38x | 6.47x |
EV/EBITDA | -8.27x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -6.71% | -12.6% | -14.26% | -6.66% |